Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01106534
Show Display Options
Download search resultsDownload the search results for:
NCT01106534 (1 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Conditions: Chronic Total Occlusion of Coronary Artery;   Vascular Disease;   Myocardial Ischemia;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Artery Disease;   Coronary Restenosis
Intervention: Drug: DAPT

Indicates status has not been verified in more than two years